Overview

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Dienogest
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Nandrolone
Polyestradiol phosphate